The International Health Economics Association Conference took place in beautiful Cape Town from 8-12 July 2023. This is the world's leading health economics conference and the first time it has been held face-to-face since 2019. In this seminar, several Kirby attendees will present highlights of key discussions on antimicrobial resistance, universal health coverage, health equity, and the economics of risky health behaviour.
Dr Boettiger will highlight the important work presented on antimicrobial resistance (AMR), emphasising the challenges of understanding the full economic and health consequences of AMR and recent work exploring the cost-effectiveness of methods intended to reduce AMR.
Dr Shih will provide an overview of equity-informed cost-effectiveness analysis and illustrate the application of the methodology using examples from the studies presented at IHEA.
Delos Trinos will present updates on financing towards universal health coverage in low-and middle-income countries (LMICs) as discussed at IHEA, such as adaptive health technology assessments, pharmaceuticals in LMICs, gaps in costing, and provider payment mechanisms.
Speakers
 |
Dr David Boettiger David is an epidemiologist and health economist at the Kirby Institute. His research investigates the effectiveness and cost-effectiveness of interventions to reduce the global burden of adult and paediatric HIV and other infectious diseases. Recently, he has taken a keen interest in the |
|
 |
||
 |
Dr Sophy Shih Sophy Shih is a senior health economist at the Kirby Institute with extensive experiences in designing and implementing trial-based economic assessments, performing economic evaluations and building economic models. Her current research focuses on economic evaluation and health service research in point-of-care testing and treatment for HCV in Australia and HIV in Papua New Guinea. |
|
|
||
 |
John Paul Caesar Delos Trinos Paul is the Chief Scientific Officer of metaHealth Insights and Innovations, a Philippine consulting firm focusing on management, economic evaluation, technology assessment, and analytics for health. He is also a guest professorial lecturer at the De La Salle Health Science Institute, where he teaches health economics and HTA. He is pursuing his PhD at the Kirby Institute examining the cost-effectiveness of preventive chemotherapy for soil-transmitted helminth control. |